Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in active systemic juvenile idiopathic arthritis
2007-000872-18Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in systemic juvenile idiopathic arthritis (SJIA) and juvenile idiopathic arthritis (JIA) comparing Tocilizumab with Placebo (2 arms). Started Jan 2008; status: completed.
02
Drugs
tocilizumab
03
Conditions
systemic juvenile idiopathic arthritis (SJIA)juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2007-000872-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000872-18.